Literature DB >> 10595834

Pituitary apoplexy probably due to TRH and GnRH stimulation tests in a patient with acromegaly.

H S Dökmetaş1, A Selçuklu, R Colak, K Unlühizarci, F Bayram, F Keleştimur.   

Abstract

Pituitary apoplexy is the most serious and life-threatening complication of pituitary adenomas. Most of the cases occur spontaneously but it may occur also after a number of events such as the pituitary stimulation tests. We report a case of acromegaly due to a giant pituitary adenoma in which pituitary apoplexy developed 88 hours after TRH/GnRH stimulation test. The patient had severe headaches, nausea, vomiting, visual disturbance and mental alteration and the computed tomography (CT) scans revealed intratumoral and intraventricular bleeding. The pituitary mass was removed by transsphenoidal approach. The patient developed pneumonia and died on the 9th postoperative day. Pituitary apoplexy was confirmed at surgery and on histological examination. Immunohistochemical staining was positive for GH and PRL. This case indicates that pituitary apoplexy may develop several days after TRH/GnRH stimulation test.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595834     DOI: 10.1007/BF03343632

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

1.  Pituitary apoplexy with spontaneous cure of acromegaly and its possible relation to Gd-DTPA-administration.

Authors:  M Wichers; R A Kristof; W Springer; J Schramm; D Klingmüller
Journal:  Acta Neurochir (Wien)       Date:  1997       Impact factor: 2.216

2.  Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone.

Authors:  E A Masson; S L Atkin; M Diver; M C White
Journal:  Clin Endocrinol (Oxf)       Date:  1993-01       Impact factor: 3.478

3.  Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas.

Authors:  W Bonicki; A Kasperlik-Załuska; W Koszewski; W Zgliczyński; J Wisławski
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

4.  Pituitary apoplexy following the administration of gonadotrophin releasing hormone.

Authors:  M Korsić
Journal:  Clin Endocrinol (Oxf)       Date:  1994-11       Impact factor: 3.478

5.  Apoplexy of a pituitary macroadenoma as a severe complication of preoperative thyrotropin-releasing hormone (TRH) testing.

Authors:  I Szabolcs; N Késmárki; K Bor; S Czirják; O Dohán; F Slovik; M Góth; L Kovács; A Ferencz; E Rimanóczy; G Szilágyi
Journal:  Exp Clin Endocrinol Diabetes       Date:  1997       Impact factor: 2.949

6.  Pituitary apoplexy after leuprolide administration for carcinoma of the prostate.

Authors:  A Morsi; S Jamal; J D Silverberg
Journal:  Clin Endocrinol (Oxf)       Date:  1996-01       Impact factor: 3.478

7.  Infarction of FSH-secreting pituitary adenoma.

Authors:  M Korsić; N Lelas-Bahun; P Surdonja; N Besenski; S Horvat; V Plavsić
Journal:  Acta Endocrinol (Copenh)       Date:  1984-10

Review 8.  Pituitary apoplexy.

Authors:  C A Rolih; K P Ober
Journal:  Endocrinol Metab Clin North Am       Date:  1993-06       Impact factor: 4.741

9.  Pituitary apoplexy after subtotal thyroidectomy in an acromegalic patient with a large goiter.

Authors:  K Kato; M Nobori; Y Miyauchi; M Ohnisi; S Yoshida; S Oya; S Tomita; T Kino
Journal:  Intern Med       Date:  1996-06       Impact factor: 1.271

10.  Pituitary apoplexy caused by endocrine stimulation tests: a case report.

Authors:  O Okuda; H Umezawa; M Miyaoka
Journal:  Surg Neurol       Date:  1994-07
View more
  6 in total

1.  Choosing the best pre-operative management for large pituitary adenomas. Emerging questions.

Authors:  M Faustini-Fustini; A Goldoni; F Roncaroli; G Frank
Journal:  J Endocrinol Invest       Date:  2000-06       Impact factor: 4.256

2.  Surgical treatment for severe visual compromised patients after pituitary apoplexy.

Authors:  Chi-Cheng Chuang; Chen-Nen Chang; Kuo-Chen Wei; Cheng-Chih Liao; Peng-Wei Hsu; Ying-Cheng Huang; Yao-Liang Chen; Li-Ju Lai; Ping-Ching Pai
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

3.  Somatotropinoma infarction during octreotide therapy leading to bilateral cavernous sinus syndrome.

Authors:  N M Boulis; A J Noordmans; A Barkan; J Hassing; W F Chandler
Journal:  Pituitary       Date:  2000-11       Impact factor: 4.107

4.  Pituitary apoplexy associated with endocrine stimulation test: endocrine stimulation test, treatment, and outcome.

Authors:  Takahiro Yamamoto; Shigetoshi Yano; Jun-Ichiro Kuroda; Yu Hasegawa; Takuichiro Hide; Jun-Ichi Kuratsu
Journal:  Case Rep Endocrinol       Date:  2012-08-15

Review 5.  Multidisciplinary Management of Pituitary Apoplexy.

Authors:  Adriana Albani; Francesco Ferraù; Filippo Flavio Angileri; Felice Esposito; Francesca Granata; Felicia Ferreri; Salvatore Cannavò
Journal:  Int J Endocrinol       Date:  2016-12-15       Impact factor: 3.257

6.  Pituitary Adenoma Apoplexy: Review of Personal Series.

Authors:  Riccardo Ricciuti; Niccolò Nocchi; Giorgio Arnaldi; Gabriele Polonara; Michele Luzi
Journal:  Asian J Neurosurg       Date:  2018 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.